Nodular fasciitis: A novel model of transient neoplasia induced by MYH9-USP6 gene fusion

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
Laboratory Investigation (Impact Factor: 3.83). 08/2011; 91(10):1427-33. DOI: 10.1038/labinvest.2011.118
Source: PubMed

ABSTRACT Nodular fasciitis (NF) is a relatively common mass-forming and self-limited subcutaneous pseudosarcomatous myofibroblastic proliferation of unknown pathogenesis. Due to its rapid growth and high mitotic activity, NF is often misdiagnosed as a sarcoma. While studying the USP6 biology in aneurysmal bone cyst and other mesenchymal tumors, we identified high expression levels of USP6 mRNA in two examples of NF. This finding led us to further examine the mechanisms underlying USP6 overexpression in these lesions. Upon subsequent investigation, genomic rearrangements of the USP6 locus were found in 92% (44 of 48) of NF. Rapid amplification of 5'-cDNA ends identified MYH9 as the translocation partner. RT-PCR and direct sequencing revealed the fusion of the MYH9 promoter region to the entire coding region of USP6. Control tumors and tissues were negative for this fusion. Xenografts of cells overexpressing USP6 in nude mice exhibited clinical and histological features similar to human NF. The identification of a sensitive and specific abnormality in NF holds the potential to be used diagnostically. Considering the self-limited nature of the lesion, NF may represent a model of 'transient neoplasia', as it is, to our knowledge, the first example of a self-limited human disease characterized by a recurrent somatic gene fusion event.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: The skeletal system may be affected by a variety of nonneoplastic lesions, which may potentially be confused with primary bone tumors on clinical, radiologic, and pathologic grounds. These conditions include fractures, infections, and reactive and degenerative processes, as well as an array of quasineoplastic entities, such as intramedullary cystic lesions like unicameral and aneurysmal bone cysts; fibro-osseous lesions, such as fibrous dysplasia; and exophytic entities, like osteochondromas. To review clinical, radiographic, and histologic features of nonneoplastic lesions of bone, discussing the difficulties in diagnosis and the differential diagnosis with primary neoplasms of bone. The sources include the more relevant medical literature on the different subjects and case-derived material. Because many nonneoplastic bone lesions may require biopsy or resection, the general surgical pathologist must be familiar with these lesions and be aware that review of hematoxylin-eosin slides is only one of the many steps in the diagnostic process, which also includes review of imaging studies and all available clinical information. Morphologic analysis disconnected from the clinical and radiographic context may lead to misinterpretation.
    Archives of pathology & laboratory medicine 07/2012; 136(7):772-88. DOI:10.5858/arpa.2011-0557-RA · 2.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: SOFT TISSUE TUMORS ARE CLASSIFIED ACCORDING TO THEIR HISTOLOGICAL RESEMBLANCE TO NORMAL ADULT TISSUES AND CAN BE GROUPED INTO THE FOLLOWING CATEGORIES BASED ON METASTATIC POTENTIAL: benign, intermediate (locally aggressive), intermediate (rarely metastasizing) and malignant. Over the past two decades, considerable progress has been made in our understanding of the genetic background of soft tissue tumors. Traditional laboratory techniques, such as cytogenetic analysis and fluorescence in situ hybridization (FISH), can be used for diagnostic purposes in soft tissue pathology practice. Moreover, cytogenetic and molecular studies are often necessary for prognostics and follow-up of soft tissue sarcoma patients. This review provides updated information on the applicability of laboratory genetic testing in the diagnosis of benign and intermediate soft tissue tumors. These tumors include nodular fasciitis, chondroid lipoma, collagenous fibroma (desmoplastic fibroblastoma), giant cell tumor of tendon sheath (GCTTS)/pigmented villonodular synovitis (PVNS), angiofibroma of soft tissue, myxoinflammatory fibroblastic sarcoma (MIFS) and ossifying fibromyxoid tumor (OFMT).
    Oncology letters 01/2013; 5(1):12-18. DOI:10.3892/ol.2012.1002 · 0.99 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A large group of relatively common soft tissue tumors are composed of a mixture of fibroblasts and myofibroblasts. Fibroblasts are slender cells with elongated tapered or serpiginous nuclei and little cytoplasm. Myofibroblasts tend to be plumper and have oval nuclei, each with a small distinct nucleolus, and variable amounts of amphophilic cytoplasm according to the functional state of the cells. Both have contractile and (stromal) secretory properties and can modulate into fibroblasts. Cell margins are poorly defined and tend to blend into adjacent collagen. Nuclear pleomorphism sometimes is a feature in both reactive and neoplastic conditions.
    Atlas of Soft Tissue Tumor Pathology, 01/2013: pages 23-36; , ISBN: 978-1-4614-7024-3
Show more